| Style | Citing Format |
|---|---|
| MLA | M Shafiei MOHAMMAD, Ma Faramarzi Mohammad ALI, S Mojtabavi SOMAYEH. "From Code to Cure: Ai-Driven Innovation in Monoclonal Antibody Development." DARU, Journal of Pharmaceutical Sciences, vol. 33, no. 2, 2025, pp. -. |
| APA | M Shafiei MOHAMMAD, Ma Faramarzi Mohammad ALI, S Mojtabavi SOMAYEH (2025). From Code to Cure: Ai-Driven Innovation in Monoclonal Antibody Development. DARU, Journal of Pharmaceutical Sciences, 33(2), -. |
| Chicago | M Shafiei MOHAMMAD, Ma Faramarzi Mohammad ALI, S Mojtabavi SOMAYEH. "From Code to Cure: Ai-Driven Innovation in Monoclonal Antibody Development." DARU, Journal of Pharmaceutical Sciences 33, no. 2 (2025): -. |
| Harvard | M Shafiei MOHAMMAD, Ma Faramarzi Mohammad ALI, S Mojtabavi SOMAYEH (2025) 'From Code to Cure: Ai-Driven Innovation in Monoclonal Antibody Development', DARU, Journal of Pharmaceutical Sciences, 33(2), pp. -. |
| Vancouver | M Shafiei MOHAMMAD, Ma Faramarzi Mohammad ALI, S Mojtabavi SOMAYEH. From Code to Cure: Ai-Driven Innovation in Monoclonal Antibody Development. DARU, Journal of Pharmaceutical Sciences. 2025;33(2):-. |
| BibTex | @article{ author = {M Shafiei MOHAMMAD and Ma Faramarzi Mohammad ALI and S Mojtabavi SOMAYEH}, title = {From Code to Cure: Ai-Driven Innovation in Monoclonal Antibody Development}, journal = {DARU, Journal of Pharmaceutical Sciences}, volume = {33}, number = {2}, pages = {-}, year = {2025} } |
| RIS | TY - JOUR AU - M Shafiei MOHAMMAD AU - Ma Faramarzi Mohammad ALI AU - S Mojtabavi SOMAYEH TI - From Code to Cure: Ai-Driven Innovation in Monoclonal Antibody Development JO - DARU, Journal of Pharmaceutical Sciences VL - 33 IS - 2 SP - EP - PY - 2025 ER - |